VIA
NAMS icon

Virtus Investment Advisers’s NewAmsterdam Pharma NAMS Stock Holding History

Virtus Investment Advisers’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
10,763
+3,444
+47% +$113K 0.09% 332
2026
Q1 		$234K Buy
7,319
+177
+2% +$5.76K 0.06% 320
2025
Q4 		$251K Buy
7,142
+1,731
+32% +$63K 0.07% 332
2025
Q3 		$154K Buy
5,411
+940
+21% +$22.5K 0.04% 373
2025
Q2 		$81K Sell
4,471
-2,072
-32% -$37.8K 0.03% 421
2025
Q1 		$134K Buy
+6,543
New +$145K 0.04% 368

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Virtus Investment Advisers's NAMS Position: Q2 2026 in Review

Virtus Investment Advisers increased its NewAmsterdam Pharma (NAMS) stake by 47% in Q2 2026, buying an estimated $113K and bringing the position to 10,763 shares worth $365K. The position accounts for 0.09% of the portfolio, ranked #332.

Virtus Investment Advisers first reported a position in NAMS in Q1 2025 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Virtus Investment Advisers held 10,763 shares of NewAmsterdam Pharma worth $365K as of Q2 2026.
  • Virtus Investment Advisers bought 3,444 NewAmsterdam Pharma shares in Q2 2026, an estimated $113K.
  • NewAmsterdam Pharma made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #332 holding.
  • Virtus Investment Advisers first reported a position in NewAmsterdam Pharma in Q1 2025 and has held it in 6 quarters since.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.